Is $SPRY pump-proof?

ARS Pharmaceuticals, Inc.: trap-risk read from social crowding, price extension, and SEC disclosure flags. Updated 2026-10-23.

$SPRY
ARS Pharmaceuticals, Inc.
CLEAR RISK
13
/ 100 trap score
Boring, in the best way. No run-up, no crowding, and a clean recent filing history.
Hype / crowding
13
Run-up / extension
15
Structural risk
10
~Automatic shelf (S-3ASR) on file 1.7 years ago: routine for large issuers (often debt), low dilution signal [S-3ASR 2025-01-31]↗
🔒 1 more filing flagged on $SPRY: see all of them free.
All 2 flags + filing links, free. No spam, unsubscribe anytime.
PumpProof · pumpproof.com
as of 2026-10-23 · not financial advice

The record on $SPRY

first scored Sep 7: -23% since
9Sep 7
8Oct 10
8Oct 11
8Oct 12
10Oct 17
8Oct 19
12Oct 21
13Oct 23
Every score we publish is snapshotted the day it runs. Wins and misses stay on the record. Full ledger in the Friday email.
What these filings mean
What a shelf registration is →How share dilution works →All the filing explainers →
Check any other ticker free at pumpproof.com

Get the Sunday watchlist before Monday's open

Every Sunday evening: the names heating up on weekend chatter before they hit this board, scored against their filings. Plus Friday receipts: how every score aged, wins and misses. Free, in your inbox.